A61P 17 - Drugs for dermatological disorders

Patents for A61P 17 - Drugs for dermatological disorders (106,455)
01/2007
01/02/2007	CA2376668C Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them
01/02/2007	CA2289817C 2-amino-4-alkylamino-3-pyrimidine oxides as soothing agents
01/02/2007	CA2218892C Diaromatic propynyl or dienyl compounds
01/02/2007	CA2214899C Process for glucan preparation and therapeutic uses of glucan
12/2006
12/28/2006	WO2006138468A2 Use of vegf for wound healing
12/28/2006	WO2006138056A1 Pharmaceutical composition comprising a mahonia aquifolium extract for the treatment of psoriasis
12/28/2006	WO2006138038A1 Intralesional treatment of psoriasis
12/28/2006	WO2006137513A1 Promoter of differentiation and keratinization of epidermic cell and functional beverage/food for promotion of keratinization of epidermis
12/28/2006	WO2006137509A1 Cyclic amine derivative containing ppar regulator
12/28/2006	WO2006137469A1 Metabotropic glutamate receptor activator
12/28/2006	WO2006137450A1 Crystal of phenylalanine derivative, process for producing the same and use thereof
12/28/2006	WO2006137421A1 Agent for topical administration
12/28/2006	WO2006137377A1 Neuronal regeneration promoter
12/28/2006	WO2006137314A1 Radial brush
12/28/2006	WO2006136540A2 Human skin regenerating ointment comprising annelid extracts
12/28/2006	WO2006136244A2 Use of adipose tissue-derived stromal stem cells in treating fistula
12/28/2006	WO2006136081A1 A composition containing coenzyme q10 for treating dermatopathy, and its preparation method
12/28/2006	WO2006135965A1 Composition for treating skin lesions
12/28/2006	WO2006123031A3 Pharmaceutical composition comprising an oleaginous ointment and vitamin d or the derivatives thereof in solubilised form
12/28/2006	WO2006102899A3 Oxaprozin or closely related compound for the treatment and prevention of
12/28/2006	WO2006102898A3 Oxaprozin or a closely related compound for the treatment of eczema
12/28/2006	WO2005094796A3 Methods for interfering with fibrosis
12/28/2006	WO2003072714A3 Follistatin domain containing proteins
12/28/2006	US20060293527 Analogs of epothilone
12/28/2006	US20060293351 Promotion of wound healing
12/28/2006	US20060293348 CSBP/p38 kinase inhibitor; antiinflammatory agent; inflammatory bowel disease; tuberculosis, atherosclerosis, muscle degeneration, cachexia, psoriatic arthritis, rheumatoid arthritis; 8-(2,4,6-trifluorophenyl)-4-(2,4-difluorophenyl)-2-(2-hydroxy-1-hydroxymethylethylamino)-8H-pyridio[2,3]pyrimidin-7-one
12/28/2006	US20060293347 Pharmaceutically active compounds
12/28/2006	US20060293335 Riboflavin derivative and its manufacture and uses
12/28/2006	US20060293332 Sulfonylquinoxalone derivatives and related compounds as bradykinin antagonists
12/28/2006	US20060293326 2-Heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases
12/28/2006	US20060293297 Cyanofluoropyrrolidine derviative
12/28/2006	US20060293291 bone formation is desired, such as osteoporosis, as well as autoimmune diseases such as multiple sclerosis, diabetes mellitus and lupus; exhibit pronounced activity in arresting the proliferation of undifferentiated cells; 2-[(3'-methoxymethoxy)propylidene]-19-nor-1 alpha ,25-(OH)2,D3
12/28/2006	US20060293278 Novel therapeutic uses of glucan
12/28/2006	US20060293275 Hgf production accelerator containing heparin-like oligosaccharide
12/28/2006	US20060293252 such as 3-(4-Methoxy-phenyl)-1-[3-(3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-thiophen-2-yl]-propan-1-one; for use as antidiabetics
12/28/2006	US20060292185 Topical skin preparations for treatment of skin aging comprising a testosterone ester
12/28/2006	US20060292184 Bioadhesive liquid composition which is substantially free of water
12/28/2006	US20060292131 Chondrocyte Therapeutic Delivery System
12/28/2006	US20060292126 Epidermal and dermal equivalents
12/28/2006	US20060292112 Dendrimer-photosensitizer complexes for medical applications
12/28/2006	US20060292093 Chromen-4-one derivatives
12/28/2006	DE4403989B4 Pharmazeutische und/oder kosmetische Zusammensetzung sowie die Verwendung einer derartigen Zusammensetzung Pharmaceutical and / or cosmetic composition and the use of such a composition
12/28/2006	DE102005026061A1 Depolymerisiertes Scleroglucan zur Regulierung und Verbesserung des Feuchtigkeitsgehaltes der Haut Depolymerized scleroglucan for regulating and improving the moisture content of the skin
12/28/2006	DE102005008299A1 Cosmetic and/or dermatological formulation, useful as e.g. antiseptic, comprises metallic silver as active agent, auxiliary- and basic- materials
12/28/2006	CA2633030A1 Intralesional treatment of psoriasis
12/28/2006	CA2614111A1 Promoter of differentiation and keratinization of epidermic cell and functional beverage/food for promotion of keratinization of epidermis
12/28/2006	CA2613457A1 Use of adipose tissue-derived stromal stem cells in treating fistula
12/28/2006	CA2613297A1 Composition for treating skin lesions
12/28/2006	CA2613253A1 Combination comprising amino alcohol derivatives as immunosuppressants
12/28/2006	CA2613249A1 Crystals of phenylalanine derivatives, production method thereof and use thereof
12/28/2006	CA2612750A1 Method and composition to treat skin ulcers
12/28/2006	CA2612408A1 Pharmaceutical composition comprising a mahonia aquifolium extract for the treatment of psoriasis
12/28/2006	CA2612233A1 Use of vegf for wound healing
12/28/2006	CA2598216A1 Androgen receptor modulator compounds and methods
12/27/2006	EP1736547A1 Guanylate binding protein (GBP-1) as inhibitor of cell proliferation
12/27/2006	EP1736541A1 Novel galectin 9 modification protein and use thereof
12/27/2006	EP1736470A2 Pyrimidine derivatives as CB2 cannabinoid receptor modulators
12/27/2006	EP1736157A1 Anti-itching agent
12/27/2006	EP1736152A2 Physiologically stable compositions of butyric acid as well as butyric acid salts and derivatives for treating wounds
12/27/2006	EP1735348A1 Human anti-epidermal growth factor receptor antibody
12/27/2006	EP1735298A1 Piperidine derivates for the treatment of chemokines mediared disease
12/27/2006	EP1735277A1 2-alkylidene-18,19-dinor-vitamin d compounds
12/27/2006	EP1735001A2 Pharmaceutical compositions for the treatment of skin diseases comprising a combination of epinastine and one or more additional minerals or one or more crude drugs
12/27/2006	EP1734952A1 Protein kinase c inhibitors for the treatment of autoimmune diseases and of transplant rejection
12/27/2006	EP1534682B1 Novel molecules derived from noraporphine
12/27/2006	EP1480961B1 Glutaminyl based dpiv inhibitors
12/27/2006	EP1443925B1 Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors
12/27/2006	EP1430051B1 N-(4-(4-methylthiazol-5-yl)pyrimidin-2-yl)-n-phenylamines as antiproliferative compounds
12/27/2006	EP1427423B1 Benzothiazepine and benzothiadiazepine derivatives with ileal bile acid transport (ibat) inhibitory activity for the treatment hyperlipidaemia
12/27/2006	EP1406876B1 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors
12/27/2006	EP1392276B1 Potentiation of therapeutic effects of polyunsaturated fatty acids
12/27/2006	EP1354047B1 Methods for screening compounds that modulate lipid metabolism
12/27/2006	EP1339422B1 Histaminase of vegetable origin for use in the treatment of allergic and septic shock and of allergic asthma
12/27/2006	EP1332372B1 Net, a transcription factor of the tcf family, as regulator of angiogenic factor expression
12/27/2006	EP1313695B1 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
12/27/2006	EP1299374B1 Novel non-psychotropic cannabinoids
12/27/2006	EP1226144B1 Alkylamino substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase
12/27/2006	EP1105505B1 Compound and method for the prevention and/or the treatment of allergy
12/27/2006	CN1886423A Glycoisoforms of adiponectin and uses thereof
12/27/2006	CN1886403A Use of a compound of formula (i) as an inhibitor of aromatase for therapeutic purposes and compounds of formula (1) thereas
12/27/2006	CN1886375A Piperidine compound and method for producing same
12/27/2006	CN1886150A Fibroblast-mobilizing agent containing g-csf and wound remedy
12/27/2006	CN1886146A Compositions for the treatment of atopic dermatitis, skin allergic conditions and acne
12/27/2006	CN1883702A Medicine for treating deep erosive trauma with crust
12/27/2006	CN1883699A Medicine with green vitriol for treating armpit odor
12/27/2006	CN1883696A Hair quickly regenerating liquid
12/27/2006	CN1883680A Medicine with stemona root for removing armpit odor
12/27/2006	CN1883677A Powder for treating beriberi and preparation method thereof
12/27/2006	CN1883667A Pure natural essence for beautifying and estrogen supplementation for women and preparation method thereof
12/27/2006	CN1883662A Pharmaceutical composition for treating psoriasis
12/27/2006	CN1883659A Chinese medicine for treating skin lesion and malignant tumor and application thereof
12/27/2006	CN1883657A Chinese medicinal formulation for treating psoriasis and using method thereof
12/27/2006	CN1883649A Medicine for removing armpit odor
12/27/2006	CN1883645A Composition for treating acne mainly
12/27/2006	CN1883630A Oral liquid for treating traumatic injury and method for preparing same
12/27/2006	CN1883627A Medicinal powder with grassleaved sweetflag for treating tragomaschalia
12/27/2006	CN1883622A Externally applied medicine for treating dermatosis and preparation method thereof
12/27/2006	CN1883621A Medicine for treating angiitis sore of diabetic foot and method for preparing same
12/27/2006	CN1883620A Gel agent for treating superficial mycotic infection and method for preparing same
12/27/2006	CN1883614A Formulation of hair-blackening tonic and preparation method thereof

1 ... 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 ... 1065